MR (mineralocorticoid receptor) activation in the heart plays a central role in the development of cardiovascular disease, including heart failure. The MR is present in many cell types within the myocardium, including cardiomyocytes, macrophages and the coronary vasculature. The specific role of the MR in each of these cell types in the initiation and progression of cardiac pathophysiology is not fully understood. Cardiomyocyte MRs are increasingly recognized to play a role in regulating cardiac function, electrical conduction and fibrosis, through direct signal mediation and through paracrine MR-dependent activity. Although MR blockade in the heart is an attractive therapeutic option for the treatment of heart failure and other forms of heart disease, current antagonists are limited by side effects owing to MR inactivation in other tissues (including renal targets). This has led to increased efforts to develop therapeutics that are more selective for cardiac MRs and which may have reduced the occurrence of side effects in non-cardiac tissues. A major clinical consideration in the treatment of cardiovascular disease is of the differences between males and females in the incidence and outcomes of cardiac events. There is clinical evidence that female sensitivity to endogenous MRs is more pronounced, and experimentally that MR-targeted interventions may be more efficacious in females. Given that sex differences have been described in MR signalling in a range of experimental settings and that the MR and oestrogen receptor pathways share some common signalling intermediates, it is becoming increasingly apparent that the mechanisms of MRs need to be evaluated in a sex-selective manner. Further research targeted to identify sex differences in cardiomyocyte MR activation and signalling processes has the potential to provide the basis for the development of cardiac-specific MR therapies that may also be sex-specific.
Skip Nav Destination
Article navigation
Review Article|
June 27 2013
Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte
Laura A. Bienvenu;
Laura A. Bienvenu
*Prince Henry's Institute of Medical Research, Clayton, VIC 3168, Australia
†Department of Physiology, University of Melbourne, Parkville, VIC 3010, Australia
Search for other works by this author on:
Melissa E. Reichelt;
Melissa E. Reichelt
†Department of Physiology, University of Melbourne, Parkville, VIC 3010, Australia
Search for other works by this author on:
Lea M. D. Delbridge;
Lea M. D. Delbridge
†Department of Physiology, University of Melbourne, Parkville, VIC 3010, Australia
Search for other works by this author on:
Morag J. Young
*Prince Henry's Institute of Medical Research, Clayton, VIC 3168, Australia
Correspondence: Dr Morag J. Young (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
February 04 2013
Revision Received:
April 02 2013
Accepted:
May 02 2013
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2013 Biochemical Society
2013
Clin Sci (Lond) (2013) 125 (9): 409–421.
Article history
Received:
February 04 2013
Revision Received:
April 02 2013
Accepted:
May 02 2013
Citation
Laura A. Bienvenu, Melissa E. Reichelt, Lea M. D. Delbridge, Morag J. Young; Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte. Clin Sci (Lond) 1 November 2013; 125 (9): 409–421. doi: https://doi.org/10.1042/CS20130050
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |